Indeed, it has been postulated that the anti-inflammatory effects of LDMTX in RA are separate from its DHFR activity, but rather are due to other mechanisms including adenosine accumulation, impaired T cell activation, and even inhibition of IL-1β/IL-1β receptor interactions (6, 24, 25). The gene discussed is IL1B; the disease is rheumatoid arthritis.